PT1318791E - Composicao farmaceutica semi-solida de isotretinoina - Google Patents

Composicao farmaceutica semi-solida de isotretinoina

Info

Publication number
PT1318791E
PT1318791E PT01969090T PT01969090T PT1318791E PT 1318791 E PT1318791 E PT 1318791E PT 01969090 T PT01969090 T PT 01969090T PT 01969090 T PT01969090 T PT 01969090T PT 1318791 E PT1318791 E PT 1318791E
Authority
PT
Portugal
Prior art keywords
pharmaceutical composition
isotretinoin
semi
solid pharmaceutical
hydrophilic
Prior art date
Application number
PT01969090T
Other languages
English (en)
Inventor
Francis Vanderbist
Cecile Servais
Philippe Baudier
Original Assignee
Galephar M F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3862550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1318791(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galephar M F filed Critical Galephar M F
Publication of PT1318791E publication Critical patent/PT1318791E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT01969090T 2000-09-22 2001-09-21 Composicao farmaceutica semi-solida de isotretinoina PT1318791E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE0000111 2000-09-22

Publications (1)

Publication Number Publication Date
PT1318791E true PT1318791E (pt) 2004-11-30

Family

ID=3862550

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01969090T PT1318791E (pt) 2000-09-22 2001-09-21 Composicao farmaceutica semi-solida de isotretinoina

Country Status (10)

Country Link
US (5) US7435427B2 (pt)
EP (1) EP1318791B1 (pt)
AT (1) ATE270544T1 (pt)
AU (1) AU2001289438A1 (pt)
BR (1) BR102013032172A2 (pt)
CA (1) CA2423170A1 (pt)
DE (1) DE60104206T2 (pt)
ES (1) ES2225600T3 (pt)
PT (1) PT1318791E (pt)
WO (1) WO2002024172A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2376400A1 (en) 1999-06-08 2000-12-14 University Of Iowa Research Foundation Compounds and methods to enhance raav transduction
DE60104206T2 (de) 2000-09-22 2005-09-22 Galephar M/F Halbfeste arzneizubereitung enthaltend isotretinoin
ITMI20011338A1 (it) * 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
FI20030426A (fi) * 2003-03-24 2004-09-25 Tomi Jaervinen Syklodekstriinikompleksit
AU2004227358B8 (en) 2003-03-31 2009-12-10 Targeted Genetics Corporation Compounds and methods to enhance rAAV transduction
SE0303135D0 (sv) * 2003-11-25 2003-11-25 Lipocore Holding Ab Controlled food effect composition
WO2006102157A1 (en) * 2005-03-21 2006-09-28 Ivax Pharmaceuticals S.R.O. Crystallization inhibitor and its use in gelatin capsules
CN101610754A (zh) * 2007-02-16 2009-12-23 Aska制药株式会社 含有微粒油性混悬液的药物组合物
WO2010109259A1 (es) * 2009-03-26 2010-09-30 Grufarcol Ltda Métoda para preparar formulaciones de gel blando de isotretinoína líquida y la formulaciones obtenidas
MX2011012233A (es) 2009-05-20 2012-04-19 Ranbaxy Lab Ltd Soluciones de retinoide topicas.
BRPI1010970A2 (pt) 2009-05-20 2019-04-09 Ranbaxy Laboratories Limited solução farmacêutica, processo para preparar uma solução farmacêutica e método para tratamento
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
US9078925B2 (en) * 2012-06-18 2015-07-14 Galephar Pharmaceutical Research, Inc. Pharmaceutical semi-solid composition of isotretinoin
CN105580229B (zh) 2013-09-25 2019-03-26 3M创新有限公司 用于电场分级的组合物
US10143657B2 (en) * 2014-01-17 2018-12-04 Oncoral Pharma Aps Solid oral dosage form of irinotecan for the treatment of cancer
BR112016028083A2 (pt) * 2014-05-29 2017-08-22 Sun Pharmaceutical Ind Ltd Composição oral farmacêutica de isotretinoina e seu processo de preparação
MA40313A (fr) * 2014-06-02 2017-04-05 Sun Pharmaceutical Ind Ltd Composition pharmaceutique à base d'isotrétinoïne destinée à la voie orale
CA2956831A1 (en) 2014-07-31 2016-02-04 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition of isotretinoin
US9750711B2 (en) 2014-10-01 2017-09-05 Sun Pharmaceutical Industries Limited Low dose oral pharmaceutical composition of isotretinoin
MA40781A (fr) * 2014-10-01 2017-08-08 Sun Pharmaceutical Ind Ltd Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale
WO2016189481A1 (en) * 2015-05-25 2016-12-01 Sun Pharmaceutical Industries Limited Once daily oral pharmaceutical composition of isotretinoin
EP3302438A4 (en) * 2015-05-29 2019-01-09 Sun Pharmaceutical Industries Ltd ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
WO2017139381A1 (en) 2016-02-08 2017-08-17 University Of Iowa Research Foundation Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
CA3198936A1 (en) 2016-03-07 2017-09-14 University Of Iowa Research Foundation Aav-mediated expression using a synthetic promoter and enhancer
WO2017189995A1 (en) 2016-04-28 2017-11-02 Amplipharm Pharmaceuticals, LLC Temozolomide powder formulation
US9949967B2 (en) 2016-04-28 2018-04-24 Amplipharm Pharmaceuticals, LLC Temozolomide powder formulation
US10285987B2 (en) 2017-04-28 2019-05-14 Amplipharm Pharmaceuticals, LLC Device and kit for dosing and dispensing non-liquid medicine
WO2017203365A1 (en) 2016-05-26 2017-11-30 Dr. Reddy's Laboratiories Ltd. Pharmaceutical compositions for treating acne
US11142775B2 (en) 2017-01-13 2021-10-12 University Of Iowa Research Foundation Bocaparvovirus small noncoding RNA and uses thereof
CA3061125C (en) * 2017-04-28 2022-05-24 Amplipharm Pharmaceuticals, LLC Device and kit for dosing and dispensing non-liquid medicine
KR20200135931A (ko) 2017-06-29 2020-12-04 스카이라인 바이오사이언시즈, 엘엘씨 이소트레티노인 구강-점막 제제 및 그의 사용 방법
US10716774B1 (en) 2018-01-05 2020-07-21 Yale Pharmaceuticals LLC Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability
EP4236915A1 (en) * 2020-11-01 2023-09-06 Idrs Labs Pvt Ltd Oral liquid pharmaceutical compositions of isotretinoin
WO2024006748A1 (en) 2022-07-01 2024-01-04 Acrotech Biopharma Inc. Pharmaceutical compositions comprising isotretinoin and processes for preparation and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
US4530213A (en) 1983-06-28 1985-07-23 Air Products And Chemicals, Inc. Economical and thermally efficient cryopump panel and panel array
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
CA1282326C (en) * 1984-12-14 1991-04-02 Paul J. Jarosz Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
US5252604A (en) * 1992-07-10 1993-10-12 Hoffmann-La Roche Inc. Compositions of retinoic acids and tocopherol for prevention of dermatitis
US6054136A (en) 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
US5993585A (en) * 1998-01-09 1999-11-30 Nike, Inc. Resilient bladder for use in footwear and method of making the bladder
US6020003A (en) * 1998-02-23 2000-02-01 Basf Corporation Method of making spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin
FR2775597B1 (fr) 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
KR100336090B1 (ko) * 1998-06-27 2002-05-27 윤승원 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
PE20001227A1 (es) * 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
WO2000025572A1 (en) 1998-11-04 2000-05-11 Jagjit Singh Kaurah Improved automatic plant watering system and water level control
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6624154B1 (en) * 1999-04-23 2003-09-23 Bristol-Myers Squibb Company Compositions and methods for treatment of hyperproliferative diseases
WO2001013957A2 (en) * 1999-08-24 2001-03-01 Cellgate, Inc. Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
US6267798B1 (en) * 2000-02-02 2001-07-31 Nuflux, Llc Composition for treating steel making slags
IN192188B (pt) * 2000-06-16 2004-03-13 Ranbaxy Lab Ltd
DE60104206T2 (de) 2000-09-22 2005-09-22 Galephar M/F Halbfeste arzneizubereitung enthaltend isotretinoin
BRPI1010970A2 (pt) 2009-05-20 2019-04-09 Ranbaxy Laboratories Limited solução farmacêutica, processo para preparar uma solução farmacêutica e método para tratamento
RU2400226C1 (ru) 2009-06-08 2010-09-27 Юрий Степанович Макляков Способ лечения угревой болезни

Also Published As

Publication number Publication date
ES2225600T3 (es) 2005-03-16
US20040009225A1 (en) 2004-01-15
US8367102B2 (en) 2013-02-05
US20130158119A1 (en) 2013-06-20
US7435427B2 (en) 2008-10-14
EP1318791A1 (en) 2003-06-18
US20080171084A1 (en) 2008-07-17
US20130096196A1 (en) 2013-04-18
AU2001289438A1 (en) 2002-04-02
DE60104206T2 (de) 2005-09-22
BR102013032172A2 (pt) 2017-10-24
US20130217769A1 (en) 2013-08-22
CA2423170A1 (en) 2002-03-28
ATE270544T1 (de) 2004-07-15
EP1318791B1 (en) 2004-07-07
DE60104206D1 (de) 2004-08-12
US9089534B2 (en) 2015-07-28
US8952064B2 (en) 2015-02-10
WO2002024172A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
PT1318791E (pt) Composicao farmaceutica semi-solida de isotretinoina
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
PT1140993E (pt) Derivados de glicopeptidos e composicoes farmaceuticas contendo os mesmos
AR021844A1 (es) Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion
EA200300050A1 (ru) Гликопептидфосфонатные производные
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
CO4910133A1 (es) Antagonistas de 5-h[1f]
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
ATE231872T1 (de) Thiazolopyrimidinderivate
BR9810495A (pt) Composição farmacêutica
CY1105247T1 (el) Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης
ES2181744T3 (es) Hidratos de paclitaxel cristalinos.
RS54275B1 (sr) Vodeni 2,6-diizopropilfenol farmaceutski sastavi
CY1106682T1 (el) Ενωση λακταμης
ATE406161T1 (de) Kombination aus tenofovir, ritonavir und tmc114
ATE530197T1 (de) Medizinische zusammensetzungen zur angiogenese- therapie
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
BR9900114A (pt) Composições de ciclodextrina.
AR024959A1 (es) Una composicion farmaceutica liquida basada en paracetamol
SE9801494D0 (sv) Novel use
DE69936052D1 (de) N1 modifizierte glycopeptide
MA27922A1 (fr) Formulations semi-solides de derives d'azetidine